The pharmaceutical export promotion council of India (PHARMEXCIL), the apex body of pharma exporters from the county in league with the Union Ministry of Commerce and Industry (CIM) is organizing a Three day International Exhibition and Expo on Pharma and Healthcare (IPHEX 2024) from August 28-30, 2024 at India Expo Mart in Greater Noida.
“The three day pharma expo IPHEX to be inaugurated by Mr Jitin Prasad, Union minister of State for Commerce & Industry will offer the domestic industry majors from India and all across the world a great platform to connect and do business. It will provide you with an opportunity to meet new and existing customers actively looking for new suppliers, or looking to assess the current progress of existing projects.” Said Mr S.V.Veeramani, Chairman , Pharmaceutical export promotion council of India (PHARMEXCIL)
“The Profile of exhibits will include Pharmaceutical Formulations, Pharmaceutical APIs, Ayush, Nutraceuticals, Health Services, Biotechnology, Biotechnology Products, R&D Services, Pharmaceutical Technologies & Consultancy, Diagnostics, Surgical Dressings, Medical Devices, Pharmaceutical Research, Clinical Trials and Custom Synthesis. More than 400 buyers from world over are expected to participate in the International Pharma and Healthcare conglomeration. The event aims to facilitate access to quality and affordable generics on a global scale.” Said Mr Veeramani.
“IPHEX has garnered international recognition and fostered collaboration within the pharmaceutical community worldwide. India’s pharma exports during the year 2023-24 stood at USD 27.84 Billion with more than 30 percent exports to the US. About 70 % of World Health Organisation’s (WHO) vaccines under essential immunization schemed served from India” said Mr Veeramani.
PHARMEXCIL is the nodal agency to represent Drugs, Pharmaceutical & Healthcare industry in the global arena. With over 4562+ members, PHARMEXCIL is mandated to help them achieve excellence in exports and facilitate overseas buyers to find suitable trade partners from the Indian pharma industry.
